Patheon Pharmaceuticals 483, Mar 2016

Patheon Pharmaceuticals 483, Mar 2016

Christopher Middendorf FDA, Lauren Smith FDA$119.00

FDA investigators audited the Patheon Pharmaceuticals facility in Cincinnati, OH, United States and issued inspectional observations (via FDA 483) on 11 Mar 2016.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 11 Mar 2016
  • Location: Cincinnati, United States